Evidence map›Paper›PMID 33945628›Full record

ArticleCancer2021

Histopathologic synoptic reporting of invasive melanoma: How reliable are the data?

Laura A Taylor, Megan M Eguchi, Lisa M Reisch, Andrea C Radick, Hannah Shucard, Kathleen F Kerr, Michael W Piepkorn, Stevan R Knezevich, David E Elder, Raymond L Barnhill and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Primary Cutaneous Melanoma-Management in 2024.Journal of clinical medicine · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Laura A TaylorDivision of Dermatology, Department of Medicine, University of Louisville, Louisville, Kentucky.
Megan M EguchiDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Lisa M ReischDepartment of Biostatistics, University of Washington, Seattle, Washington.
Andrea C RadickDepartment of Biostatistics, University of Washington, Seattle, Washington.
Hannah ShucardDepartment of Biostatistics, University of Washington, Seattle, Washington.
Kathleen F KerrDepartment of Biostatistics, University of Washington, Seattle, Washington.
Michael W PiepkornDivision of Dermatology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
Stevan R KnezevichPathology Associates, Clovis, California.
David E ElderDepartment of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Raymond L BarnhillDepartment of Pathology, Curie Institute, Paris Sciences and Lettres Research University, Paris, France.
Joann G ElmoreDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.ORCID 0000-0002-7311-6835
University of Washington · USUniversity of California, Los Angeles · USClovis Oncology (United States) · USDélégation Paris 5 · FRHospital of the University of Pennsylvania · USUniversity of Louisville · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Reducing Errors in the Diagnosis of Melanoma and Melanocytic LesionsR01CA201376 · NCI · UNIVERSITY OF WASHINGTON · PI ELMORE, JOANN G, KERR, KATHLEEN F. · 2016 to 2020
$3.2M
NCATS NIH HHS UL1 TR002319NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA201376
6 · The paper itself

Abstract

backgroundSynoptic reporting is recommended by many guideline committees to encourage the thorough histologic documentation necessary for optimal management of patients with melanoma.

methodsOne hundred fifty-one pathologists from 40 US states interpreted 41 invasive melanoma cases. For each synoptic reporting factor, the authors identified cases with "complete agreement" (all participants recorded the same value) versus any disagreement. Pairwise agreement was calculated for each case as the proportion of pairs of responses that agreed, where paired responses were generated by the comparison of each reviewer's response with all others.

resultsThere was complete agreement among all reviewers for 22 of the 41 cases (54%) on Breslow thickness dichotomized at 0.8 mm, with pairwise agreement ranging from 49% to 100% across the 41 cases. There was complete agreement for "no ulceration" in 24 of the 41 cases (59%), with pairwise agreement ranging from 42% to 100%. Tumor transected at base had complete agreement for 26 of the 41 cases (63%), with pairwise agreement ranging from 31% to 100%. Mitotic rate, categorized as 0/mm

conclusionsThese findings alert pathologists and clinicians to the problem of interobserver variability in recording critical prognostic factors. LAY SUMMARY: This study addresses variability in the assessment and reporting of critical characteristics of invasive melanomas that are used by clinicians to guide patient care. The authors characterize the diagnostic variability among pathologists and their reporting methods in light of recently updated national guidelines. Results demonstrate considerable variability in the diagnostic reporting of melanoma with regard to the following: Breslow thickness, mitotic rate, ulceration, regression, and microscopic satellites. This work serves to alert pathologists and clinicians to the existence of variability in reporting these prognostic factors.

Indexed as

MelanomaSkin NeoplasmsHumansObserver VariationPatient Caredermatopathologyinterobserver variabilitymelanocytic skin lesionsmelanomasynoptic reports

Identifiers

PMID33945628
PMCPMC8753995
OpenAlexW3159941969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.